A
Aquestive Therapeutics Inc
NASDAQ:AQST
Aquestive Therapeutics Inc
NASDAQ:AQST
Price:
4.07 USD
3.56%
Market Closed
Updated:
Apr 29, 2024
Aquestive Therapeutics Inc
Cash from Investing Activities
|
Aquestive Therapeutics Inc
Cash from Investing Activities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
Cash from Investing Activities
-$995k
|
CAGR 3-Years
-24%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
$878m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
40%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-15%
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-16%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.2B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
See Also
What is Aquestive Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-995k
USD
-995k
USD
Based on the financial report for Dec 31, 2023, Aquestive Therapeutics Inc's Cash from Investing Activities amounts to -995k USD.
What is Aquestive Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
11%
11%
Over the last year, the Cash from Investing Activities growth was 61%. The average annual Cash from Investing Activities growth rates for Aquestive Therapeutics Inc have been -24% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
